BMY.MX

Bristol-Myers Squibb Company
MexicoMXNEQUITY DELAYED
Last price
1,120.00
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
1,120.00
Day high
Day low
Volume
Market cap
P/E (TTM)
52W range
— – 1,153.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+3.20% +4.4%
1M
+4.19% +0.9%
3M
+11.44% +9.1%
6M
+9.64% -2.2%
YTD
+14.99% +3.0%
1Y
+25.90% +5.8%
3Y
+7.69% -67.3%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on BMY.MX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $48.20B$48.30B$45.01B$46.16B -0.2%
Operating revenue $47.20B$47.26B$44.39B$45.41B -0.1%
Cost of revenue $13.94B$13.97B$10.69B$10.14B -0.2%
Gross profit $34.26B$34.33B$34.31B$36.02B -0.2%
Research & development $9.95B$11.16B$9.30B$9.51B -10.8%
Selling, general & admin $7.27B$8.41B$7.77B$7.81B -13.6%
Total operating expense $20.54B$28.45B$26.12B$26.92B -27.8%
Operating income $13.72B$5.89B$8.20B$9.10B +133.1%
Net interest income -$1.89B-$1.95B-$1.17B-$1.23B +2.9%
Pre-tax income $9.33B-$8.38B$8.44B$7.71B +211.3%
Tax provision $2.27B$554.00M$400.00M$1.37B +310.1%
Net income $7.05B-$8.95B$8.03B$6.33B +178.8%
Net income to common $7.05B-$8.95B$8.03B$6.33B +178.8%
Basic EPS 3.47-4.413.882.97 +178.7%
Diluted EPS 3.46-4.413.862.95 +178.5%
EBIT $11.22B-$6.43B$9.61B$8.95B +274.4%
EBITDA $15.23B$3.17B$19.37B$19.22B +380.7%
Basic shares 2.03B2.03B2.07B2.13B +0.3%
Diluted shares 2.04B2.03B2.08B2.15B +0.6%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
1,104.10
+1.44% from price
SMA 20
1,109.94
+0.91% from price
SMA 50
1,043.65
+7.32% from price
SMA 100
1,024.29
+9.34% from price
SMA 200
1,001.57
+11.82% from price
EMA 12
1,108.72
+1.02% from price
EMA 26
1,090.84
+2.67% from price
EMA 50
1,064.25
+5.24% from price
RSI (14)
63.3
Neutral
MACD (12,26,9)
17.88
Hist -2.13
ATR (14)
8.58
0.77% of price
Realised vol 30D
28.7%
Annualised
Bollinger upper
1,149.36
20, 2σ
Bollinger lower
1,070.51
20, 2σ
50 / 200 cross
Golden
1,043.65 vs 1,001.57
Trend bias
Above 200
+11.82%

Options chain

Account required
Expiry
Spot 1,120.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.02
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
28.7%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-15.7%
Peak to trough
Max drawdown 5Y
-57.3%
Peak to trough
ATR 14
8.58
0.77% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.